Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Illes

Showing results (21-30 of 201) with videos related to

Pageof 21
Sort By:
Expert Opinion on Drug Discovery|March 19, 2013
The h-P2X3 glycoprotein receptor as an example of integrating bioinformatics and structural researchPeter P Mager, Peter Illes
European Journal of Pharmacology|January 8, 2004
Molecular physiology of P2 receptors in the central nervous systemPeter Illes, J Alexandre Ribeiro
Current Topics in Medicinal Chemistry|April 14, 2004
Neuronal P2 receptors of the central nervous systemPeter Illes, Joaquim A Ribeiro
Purinergic Signalling|May 30, 2023
Adenosine A2A receptor-bearing GABAergic neurons in the lateral septum of the brain: novel mediators of depressive-like behaviorYa-Fei Zhao, Peter Illes
Pharmacological Reports : PR|July 19, 2016
Transplant drugs affect the expression of phase II and antioxidant enzymes in human carcinoma cells HepG2 but not in primary cultures of human hepatocytes: In vitro comparative studyRadim Vrzal, Peter Illes, Zdenek Dvorak
Molecular Neurobiology|October 24, 2007
P2X3 receptor involvement in pain statesKerstin Wirkner, Beata Sperlagh, Peter Illes
European Journal of Pharmacology|September 17, 2002
Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neuronsZoltan Gerevich, Kerstin Wirkner, Peter Illes
European Journal of Pharmacology|September 27, 2005
Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neuronsZoltan Gerevich, Christoph Müller, Peter Illes
Signal Transduction and Targeted Therapy|October 14, 2025
Two G protein-coupled receptors bind ceramides in atherosclerosis progression: targets for a new therapeutic strategyYue Han, Peter Illes, Yong Tang
Drug News & Perspectives|May 11, 2005
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnessesLaszlo Köles, Susanna Furst, Peter Illes
Pageof 21

Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
Expert Opinion on Drug Discovery|March 19, 2013
The h-P2X3 glycoprotein receptor as an example of integrating bioinformatics and structural researchPeter P Mager, Peter Illes
European Journal of Pharmacology|January 8, 2004
Molecular physiology of P2 receptors in the central nervous systemPeter Illes, J Alexandre Ribeiro
Current Topics in Medicinal Chemistry|April 14, 2004
Neuronal P2 receptors of the central nervous systemPeter Illes, Joaquim A Ribeiro
Purinergic Signalling|May 30, 2023
Adenosine A2A receptor-bearing GABAergic neurons in the lateral septum of the brain: novel mediators of depressive-like behaviorYa-Fei Zhao, Peter Illes
Pharmacological Reports : PR|July 19, 2016
Transplant drugs affect the expression of phase II and antioxidant enzymes in human carcinoma cells HepG2 but not in primary cultures of human hepatocytes: In vitro comparative studyRadim Vrzal, Peter Illes, Zdenek Dvorak
Molecular Neurobiology|October 24, 2007
P2X3 receptor involvement in pain statesKerstin Wirkner, Beata Sperlagh, Peter Illes
European Journal of Pharmacology|September 17, 2002
Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neuronsZoltan Gerevich, Kerstin Wirkner, Peter Illes
European Journal of Pharmacology|September 27, 2005
Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neuronsZoltan Gerevich, Christoph Müller, Peter Illes
Signal Transduction and Targeted Therapy|October 14, 2025
Two G protein-coupled receptors bind ceramides in atherosclerosis progression: targets for a new therapeutic strategyYue Han, Peter Illes, Yong Tang
Drug News & Perspectives|May 11, 2005
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnessesLaszlo Köles, Susanna Furst, Peter Illes
Pageof 21